| 1BV7 | A:1-99; B:1-99 | COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES |
| 1BV9 | A:1-99; B:1-99 | HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS |
| 1BWA | A:1-99; B:1-99 | HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS |
| 1BWB | A:1-99; B:1-99 | HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS |
| 1HWR | A:1-99; B:1-99 | MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS |
| 1QBR | A:1-99; B:1-99 | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY |
| 1QBS | A:1-99; B:1-99 | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY |
| 1QBT | A:1-99; B:1-99 | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY |
| 1QBU | A:1-99; B:1-99 | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY |
)
)